On Tuesday, Athira Pharma Inc (NASDAQ: ATHA) was 12.09% up from the session before settling in for the closing price of $0.33. A 52-week range for ATHA has been $0.22 – $3.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -73.94%. When this article was written, the company’s average yearly earnings per share was at 75.66%. With a float of $33.48 million, this company’s outstanding shares have now reached $39.04 million.
The extent of productivity of a business whose workforce counts for 26 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Athira Pharma Inc (ATHA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Athira Pharma Inc stocks. The insider ownership of Athira Pharma Inc is 14.24%, while institutional ownership is 45.08%. The most recent insider transaction that took place on Jul 01 ’25, was worth 2,502. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 8,526 shares at a rate of $0.29, taking the stock ownership to the 168,901 shares. Before that another transaction happened on Jul 01 ’25, when Company’s President and CEO sold 25,123 for $0.29, making the entire transaction worth $7,374. This insider now owns 325,802 shares in total.
Athira Pharma Inc (ATHA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 75.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.77% during the next five years compared to -73.94% drop over the previous five years of trading.
Athira Pharma Inc (NASDAQ: ATHA) Trading Performance Indicators
You can see what Athira Pharma Inc (ATHA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.07, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Athira Pharma Inc (ATHA)
The latest stats from [Athira Pharma Inc, ATHA] show that its last 5-days average volume of 0.39 million was inferior to 0.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.82%.
During the past 100 days, Athira Pharma Inc’s (ATHA) raw stochastic average was set at 55.64%, which indicates a significant decrease from 80.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0261 in the past 14 days, which was lower than the 0.0317 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2969, while its 200-day Moving Average is $0.4292. Now, the first resistance to watch is $0.3967. This is followed by the second major resistance level at $0.4233. The third major resistance level sits at $0.4567. If the price goes on to break the first support level at $0.3367, it is likely to go to the next support level at $0.3033. The third support level lies at $0.2767 if the price breaches the second support level.
Athira Pharma Inc (NASDAQ: ATHA) Key Stats
There are 39,042K outstanding shares of the company, which has a market capitalization of 14.45 million. As of now, sales total 0 K while income totals -96,940 K. Its latest quarter income was 0 K while its last quarter net income were -9,140 K.